Rohto Pharmaceutical Co Ltd

TSE:4527 (Japan)   Ordinary Shares
円 2931.50 (-5.13%) Mar 28
21.71
P/B:
2.79
Market Cap:
円 704.95B ($ 4.66B)
Enterprise V:
円 632.70B ($ 4.18B)
Volume:
1.22M
Avg Vol (2M):
807.17K
Also Trade In:

Business Description

Rohto Pharmaceutical Co Ltd

ISIN : JP3982400008

Share Class Description:

TSE:4527: Ordinary Shares
Description
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.
Name Current Vs Industry Vs History
Cash-To-Debt 8.5
Equity-to-Asset 0.7
Debt-to-Equity 0.04
Debt-to-EBITDA 0.23
Interest Coverage 174.37
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.95
Distress
Grey
Safe
Beneish M-Score -2.35
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 21.84
9-Day RSI 35.25
14-Day RSI 41.32
6-1 Month Momentum % -24.62
12-1 Month Momentum % 16.5

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.56
Quick Ratio 1.98
Cash Ratio 0.98
Days Inventory 151.17
Days Sales Outstanding 60.46
Days Payable 60.25

Financials

TSE:4527's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Rohto Pharmaceutical Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円) 263,564
EPS (TTM) (円) 135.05
Beta 0
Volatility % 38.72
14-Day RSI 41.32
14-Day ATR (円) 86.404456
20-Day SMA (円) 3031.775
12-1 Month Momentum % 16.5
52-Week Range (円) 2662 - 4117
Shares Outstanding (Mil) 228.14

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rohto Pharmaceutical Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Rohto Pharmaceutical Co Ltd Stock Events

Financials Calendars
Event Date Price(円)
No Event Data

Rohto Pharmaceutical Co Ltd Frequently Asked Questions

What is Rohto Pharmaceutical Co Ltd(TSE:4527)'s stock price today?
The current price of TSE:4527 is 円2931.50. The 52 week high of TSE:4527 is 円4117.00 and 52 week low is 円2662.00.
When is next earnings date of Rohto Pharmaceutical Co Ltd(TSE:4527)?
The next earnings date of Rohto Pharmaceutical Co Ltd(TSE:4527) is .
Does Rohto Pharmaceutical Co Ltd(TSE:4527) pay dividends? If so, how much?
The  Dividend Yield %  of Rohto Pharmaceutical Co Ltd(TSE:4527) is 0.78% (As of Today), Highest Dividend Payout Ratio of Rohto Pharmaceutical Co Ltd(TSE:4527) was 0.25. The lowest was 0.17. And the median was 0.21. The  Forward Dividend Yield % of Rohto Pharmaceutical Co Ltd(TSE:4527) is 0.97%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release